PTC Therapeutics starts common stock offering
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Insight Weekly: Renewables lead capacity additions; bank mergers of equals up; nickel IPOs surge
Insight Weekly: Utilities face headwinds; S&P 500 dividend hikes likely; dollar poised for rally
PTC Therapeutics Inc. started a public offering to sell 4 million of its common shares.
The company plans to grant the underwriters an option to buy up to an additional 600,000 shares.
Credit Suisse and Citigroup are acting as lead book-running managers, and RBC Capital Markets is acting as a book-running manager for the offering.
